Udit Singhal, MD
Manage Your Profile
About
Dr. Singhal is a board-certified urologic oncologist who specializes in the management of patients with kidney, prostate, bladder, testis, upper tract urothelial, and penile cancers. He completed his residency training in urology at the University of Michigan in Ann Arbor, MI, and his research fellowship training in translational science at the University of Michigan. He then completed his clinical urological oncology fellowship at the Mayo Clinic in Rochester, MN. He performs advanced open, endoscopic, laparoscopic, and robotic surgery.
Dr. Singhal’s research interests include the development and implementation of novel, precision-based diagnostics and therapeutics in all genitourinary malignancies. He has a special interest in the integration of genomics into biomarker-driven clinical trials in oncology, with the goal of optimally defining the clinical application of these tests. He has received grant funding for his research from the National Institutes of Health, National Cancer Institute, Prostate Cancer Foundation, Urology Care Foundation, University of Michigan, and industry partners. He has additionally received top honors and awards for his research from the Prostate Cancer Foundation, Urology Care Foundation, American Society of Clinical Oncology, and American Association for Cancer Research. He also serves as peer reviewer for many leading academic journals and is a member of numerous professional societies, including the American Urological Association, Society of Urologic Oncology, SWOG Cancer Research Network, SUO Clinical Trials Consortium, and the American Society of Clinical Oncology.
Qualifications
-
Urologic OncologyMayo Clinic, Rochester, USA
2023 - 2024
Postdoctoral Fellowship
-
Michigan Medicine Clinical Trials Academy IIMichigan Medicine, Ann Arbor, United States
2024 - 2024
Other
-
Methods in Clinical Cancer Research WorkshopAmerican Society of Clinical Oncology, Alexandria, United States
2024 - 2024
Other
-
Translational Research - Urologic OncologyUniversity of Michigan, Ann Arbor, USA
2021 - 2023
Postdoctoral Research
-
Thought Leaders of the FutureProstate Cancer Foundation, Santa Monica, United States
2023 - 2023
Other
-
Molecular Biology in Clinical Oncology WorkshopAmerican Association For Cancer Research, Philadelphia, United States
2022 - 2022
Other
-
Cluster Randomized Designs in Cancer Care Delivery ResearchNational Cancer Institute, Bethesda, United States
2022 - 2022
Other
-
Michigan Medicine Clinical Trials Academy IMichigan Medicine, Ann Arbor, United States
2022 - 2022
Other
-
UrologyUniversity of Michigan, Ann Arbor, USA
2016 - 2021
Residency
-
Chief ResidentUniversity of Michigan, Ann Arbor, USA
2020 - 2021
Chief Resident
-
Big Data and "Omics" Analysis in UrologyAmerican Urological Association, Linthicum, United States
2021 - 2021
Other
-
EPID 701 Fundamentals of BiostatisticsUniversity of Michigan–Ann Arbor, School of Public Health, Ann Arbor, United States
2021 - 2021
Other
-
EPID 717 Design and Conduct of Clinical TrialsUniversity of Michigan–Ann Arbor, Ann Arbor, United States
2021 - 2021
Other
-
BIOINF 527 Introduction to Bioinformatics and Computational BiologyUniversity of Michigan–Ann Arbor, Ann Arbor, United States
2021 - 2021
Other
-
Michigan Institute for Clinical and Health Research Mock Study SectionUniversity of Michigan–Ann Arbor, Ann Arbor, United States
2021 - 2021
Other
-
Michigan Mentored Research Academy R01 Bootcamp - Writing Winning NIH Grant ProposalsUniversity of Michigan–Ann Arbor, Ann Arbor, United States
2021 - 2021
Other
-
MDWright State University Boonshoft School of Medicine, USA
2011 - 2016
-
BSThe Ohio State University, Columbus, United States
2006 - 2010
Center Memberships
-
Center MemberRogel Cancer Center
-
Center MemberAI and Digital Health Innovation
Recent Publications
-
Aldous J, Jackson WC, Chase E, Covert E, Tang J, Singhal U, Morgan TM, Spratt DE, Dess RT, Schipper MJ. 2026 Sep 11;PreprintAbsolute Benefit of Androgen Deprivation Therapy With Radiotherapy for Localized Prostate Cancer.
DOI:10.64898/2026.09.10.26362669 PMID: 42818465 -
Singhal U, Jiang R, Proudfoot JA, Chase E, Suresh K, Davicioni E, Borza T, Zelefsky MJ, Davis BJ, Stish BJ, Karnes RJ, Freedland SJ, Terris MK, Aronson WJ, Cooperberg MR, Moraes FY, Berlin A, Deville C, Zaorsky NG, Roy S, Jia AY, Shoag JE, Jackson WC, Spratt DE, Schipper M, Morgan TM, Dess RT. Prostate Cancer and Prostatic Diseases, 2026 Sep 1; 29 (3): 570 - 577.Journal ArticleCharacterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer
DOI:10.1038/s41391-025-01062-8 PMID: 41366130 -
Monda SM, Else T, Zhu A, Kaffenberger SD, Humble RM, Reichert ZR, Morgan TM, Chandrasekar T, Dominguez-Valentin M, Stoffel EM, Singhal U. Urol Oncol, 2026 Jul 30;Journal ArticleGermline testing in urothelial cancer: A narrative review of evidence, guidelines, and testing frameworks.
DOI:10.1016/j.urolonc.2026.07.004 -
Roberson DS, Psutka SP, Meeks JJ, Clinton TN, Pessoa RR, Joyce DD, Singhal U, Bivalacqua TJ, Britton CJ, Kirschenbaum M, Torgerson H, Wan V, Yim K, Wang S, Lyon TD, Tyson MD, Pierorazio PM, Luckenbaugh AN, Li R, Boorjian SA, Khanna A. Journal of Urology, 2026 Apr 30; 215 (5S): e745Journal ArticleIP36-22 PERIOPERATIVE AND ONCOLOGIC OUTCOMES OF CONSOLIDATIVE SURGERY FOR ADVANCED UROTHELIAL CARCINOMA FOLLOWING INDUCTION ENFORTUMAB VEDOTIN AND PEMBROLIZUMAB: A MULTICENTER EXPERIENCE
DOI:10.1097/01.ju.0001191488.74766.a1.22 -
Nakhjiri M, Chaudhury S, Kriko Y, Orabi M, Bao L, Horn M, Avery R, Grajqevci A, Chang A, Odell D, Singhal U, Reddy RM, Borza T, Hughes T, Sabel M, Dossett L, Piche J, Aibinder W, Merajver S, Merrill N. Cancer Research, 2026 Apr 5; 86 (7_Supplement): 6961 - 6961.Journal ArticleAbstract 6961: Patient matched organoid-immune co-culture model as a predictive platform for immunotherapy response in precision oncology
DOI:10.1158/1538-7445.am2026-6961 -
Oh E, Chua Y, Bahar P, Accardo ML, Li X, Koeppe E, Monda S, Palmbos PL, Tsung I, Reichert ZR, Vaishampayan UN, Singhal U, Else T, Nguyen CB. Clinical Genitourinary Cancer, 2026 Jul 30; 23 (6):Journal ArticlePathogenic Germline Variant Prevalence and Genetic Testing Outcomes in Patients With Urothelial Carcinoma
DOI:10.1016/j.clgc.2025.102451 -
Singhal U. 2026 Mar 3;Presentation"Metastatic RCC with bulky primary: Navigating the balance between local and systematic therapy."
-
Singhal U. 2026 Mar 3;Presentation"Urology Today, Tomorrow, and in the Future: Kidney Cancer."
Featured News & Stories